RebrandingJul 28, 2026, 07:31 AM
Plus Therapeutics to Rebrand as Cerenome, Inc.; New Ticker CNSY
AI Summary
Plus Therapeutics, Inc. announced it will rebrand as Cerenome, Inc. and trade under the new Nasdaq ticker symbol CNSY, effective August 3, 2026. The company also announced it will present two posters and host a sponsored symposium at the 2026 SNO/ASCO CNS Metastases Conference. The presentations will highlight its ReSPECT-LM clinical development program and CNSide® cerebrospinal fluid diagnostic platform, focusing on improving detection, treatment, and monitoring of CNS metastases.
Key Highlights
- Plus Therapeutics to rebrand as Cerenome, Inc. effective August 3, 2026.
- New Nasdaq ticker symbol will be CNSY, replacing PSTV.
- Company to present two posters at SNO/ASCO CNS Metastases Conference, August 13–15, 2026.
- ReSPECT-LM poster on Rhenium Obisbemeda pharmacokinetics and pharmacodynamics.
- CNSide poster on economic impact of earlier detection of leptomeningeal metastases.
- Sponsored symposium on redefining management of leptomeningeal metastases on August 13, 2026.
Price Impact
More from PSTV